KOSDAQBatteries348370

Enchem

₩13,050▼ 7.71%2026-11-18 close
Market Cap
₩285.9B
Turnover
₩3.2B
Volume
240K
Shares out.
21.9M
PER
—
PBR
0.9×
EPS
-₩7,760
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Enchem: Sales Recovering, Losses Still the Test

Enchem's sales rose in the second and third quarters of 2026, yet operating and net losses have persisted for five straight quarters, leaving a return to profit as the key open question.

  1. 1

    Annual sales fell from KRW 509.8 billion in 2022 to KRW 312.8 billion in 2025, while operating margin moved from 3.0% to -25.1%.

  2. 2

    Third-quarter 2026 sales rose 20.8% year on year to KRW 109 billion, but the net loss attributable to controlling shareholders widened to KRW 59.9 billion from KRW 35.9 billion a year earlier.

  3. 3

    ESS electrolyte accounted for about 70% of supply at the Chinese subsidiary in 2025, and the company positions ESS as its next growth pillar after EVs.

  4. 4

    The company announced in June 2026 that first-quarter 2026 electrolyte sales volume rose 12.1% year on year to 12,155 tons (company-announced volume, not a periodic filing figure).

  5. 5

    The net loss attributable to controlling shareholders over the last four quarters totals KRW 168.5 billion, so no earnings-based multiple is calculated, while the price-to-book ratio sits below 1x.

02

Business structure

Enchem is a specialist maker of electrolyte, the core material in lithium-ion batteries, with its business centered on electrolyte for EVs and for ESS (energy storage systems) along with additives.

Production sites are in Korea, Georgia in the United States, Zhaojiang and Zhangjiagang in China, and Poland in Europe, and the annual capacity of the Chinese subsidiary is about 220,000 tons.

At the Chinese subsidiary, ESS electrolyte supply reached about 70% of volume in 2025, surpassing EV-use supply, according to the company.

Chinese customers include AESC, SVOLT, Lishen and ZhongQi, and as of May 2026 the CATL-bound ESS LFP electrolyte was in a quality audit at a local plant, with mass-supply approval still pending.

In Korea, Enchem is raising the share of direct contracts with large battery makers such as LG Energy Solution, according to press reports.

On the raw-material side, the company is pursuing vertical integration into LiPF6 lithium salt, which accounts for about 40% of electrolyte production cost, and it also runs NMP recycling that recovers solvent from spent electrolyte.

Next-generation products include electrolyte for silicon anodes with formulations from 5% silicon content up to 30% or more, a national sodium-ion battery research project, and electrolyte for high-nickel and LMR cells.

As of the June 2026 announcement, the company said it was in sample evaluation or supply talks with six North American, ten Chinese and seven European customers on ESS LFP electrolyte.

In competition, Chinese makers are widely described as holding the top global share positions, while Enchem is reported to be gaining North American share as FEOC rules restrict Chinese rivals' entry into the US market.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩90.3B-₩27.2B−30.2%
2025Q4₩90.2B-₩29.3B−32.4%
2026Q1₩84.1B-₩24.2B−28.8%
2026Q2₩102.3B-₩11.6B−11.3%
2026Q3₩109B-₩14.7B−13.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩509.8B₩15.4B₩21.8B3.0%7.7%131.9%
2023₩424.7B₩5.1B-₩49.3B1.2%−17.8%205.7%
2024₩365.7B-₩50.4B-₩555.4B−13.8%−117.7%139.2%
2025₩312.8B-₩78.4B-₩67.7B−25.1%−14.4%130.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual sales fell from KRW 509.8 billion in 2022 to KRW 424.7 billion in 2023 (down 16.7% year on year), KRW 365.7 billion in 2024 (down 13.9%) and KRW 312.8 billion in 2025 (down 14.5%), a three-year decline running from 2023 through 2025, with 2022 the largest year and 2025 the smallest in the 2022-2025 window.

Operating profit fell from KRW 15.4 billion in 2022 to KRW 5.12 billion in 2023 (down 66.7%), turned to an operating loss of KRW 50.4 billion in 2024, and widened to an operating loss of KRW 78.4 billion in 2025, making two straight loss years.

Operating margin went from 3.0% in 2022 to 1.2% in 2023, -13.8% in 2024 and -25.1% in 2025, a pattern in which falling sales and deteriorating profitability occurred together.

The company has said that oversupply and price competition in the Chinese market make it hard to secure profitability through volume growth alone.

Net income attributable to controlling shareholders moved from KRW 21.8 billion in 2022 to a net loss of KRW 49.3 billion in 2023, widened to a net loss of KRW 555.4 billion in 2024 and narrowed to a net loss of KRW 67.7 billion in 2025.

In 2024 the net loss attributable to controlling shareholders was far larger than the KRW 50.4 billion operating loss, indicating that non-operating items weighed heavily.

Net income including non-controlling interests is a different figure, showing a net loss of KRW 70.6 billion in 2025, so the two measures should be read separately.

At year-end 2025, total equity stood at KRW 481 billion, of which KRW 470.7 billion belonged to controlling shareholders, and total liabilities were KRW 626.5 billion. The debt ratio rose from 131.9% in 2022 to 205.7% in 2023 before easing to 130.2% in 2025.

Operating cash flow went from negative KRW 36 billion in 2022 to KRW 86.7 billion in 2023, negative KRW 48.9 billion in 2024 and KRW 800 million in 2025.

On a quarterly basis, sales were flat at KRW 90.3 billion in the third quarter of 2025 and KRW 90.2 billion in the fourth quarter, dipped to KRW 84.1 billion in the first quarter of 2026 (down 6.8% quarter on quarter), then rose to KRW 102.3 billion in the second quarter (up 21.6%) and KRW 109 billion in the third quarter (up 6.5%, and up 20.8% year on year).

Operating losses ran KRW 27.2 billion, KRW 29.3 billion, KRW 24.2 billion and KRW 11.6 billion across the third quarter of 2025 through the second quarter of 2026, then widened to KRW 14.7 billion in the third quarter of 2026, which was still narrower than a year earlier.

Net losses attributable to controlling shareholders ran KRW 35.9 billion, KRW 70.3 billion, KRW 10.4 billion, KRW 27.9 billion and KRW 59.9 billion over the same five quarters, totaling KRW 168.5 billion over the last four quarters.

Revenue growth has not yet translated into profit recovery, so whether sales gains convert into narrower losses is the central quarterly question.

05

Industry analysis

Demand for secondary batteries weakened as EV growth slowed and inventories were adjusted, but a recovery in utilization at major battery makers and expansion of ESS markets are showing early signs of improvement, according to June 2026 reporting.

ESS demand driven by North American supply-chain reshuffling and expanding AI data-center investment is cited as a new growth engine for materials makers.

In electrolyte, the additive formulation that governs cycle life and safety is the technical core, and Enchem is credited with several hundred formulations that suppress swelling at high voltage and prevent output loss at low temperatures.

The Chinese electrolyte market remains marked by oversupply and price competition, and in September 2026 the company said it was tightening profitability reviews by project and adjusting selling prices.

In the United States, FEOC rules restrict Chinese rivals' market entry, and analysts say Enchem's North American share is rising. In terms of cycle position, the center of demand is shifting from EVs toward ESS and next-generation batteries.

Electrolyte has a shelf life of three to four months and requires cold storage, so logistics and delivery management are viewed by brokers as a competitive edge. The company stresses that it is the only Korean firm to have entered the local battery supply chain in China. Some brokers see 2026 as the year Enchem enters the top three of global electrolyte share.

06

Outlook

In June 2025 the company said it planned to supply about 60,000 tons of ESS electrolyte in 2026, an increase of about 361% from roughly 13,000 tons planned for 2025. At the same time, it described expanding business with top Chinese battery makers including CATL, BYD, Gotion, SVOLT and Sunwoda.

At the end of 2025 the company said that of a new supply pipeline of roughly KRW 3 trillion, about KRW 1.5 trillion was already contracted, with first supply starting in the second quarter of 2026.

It added that talks for the remaining roughly KRW 1.5 trillion were aimed at closing within 2025 or by the first quarter of 2027. On capacity, the company in March 2025 set goals of 1.4 million tons in 2025 and 1.6 million tons in 2026.

In North America, reports from 2025 said the Georgia plant would expand to 150,000 tons by year-end 2025 and 200,000 tons during 2026, while a separate 2025 report said a planned Tennessee plant had been scrapped.

Over the medium term, the company has presented a supply system of 610,000 tons including 430,000 tons of electrolyte and 160,000 tons of recycled NMP by 2028.

As of September 2026, the Chinese business is being reshaped toward selective order intake, selling-price adjustments and cost reduction, and the company said it is negotiating price adjustments on roughly 1,000 tons per month of volume with some key customers.

A December 2025 report said the company was pursuing a three-year supply deal of about 1,000 tons with a North American silicon-battery company for its silicon-anode electrolyte.

Whether the remaining contracts are signed, whether CATL-bound ESS supply is approved, and whether the North American expansions are completed will shape the revenue path ahead.

07

Valuation

PER
—
PBR
0.9×
ROE
-39.5%
EPS
-₩7,760
BPS
₩15,589
Dividend per share
₩0

Because the net loss attributable to controlling shareholders has continued over the last four quarters, no earnings-based multiple can be calculated. The price-to-book ratio sits below 1x, which means the stock trades at a discount to net asset value.

Dilution history also matters, since convertible bonds issued at the end of 2024 saw conversion requests rise in 2025.

Net income attributable to controlling shareholders moved from profit in 2022 to losses from 2023 and has stayed in loss for three years, so comparing the current level with past earnings-based multiple ranges is difficult. Cash dividends are effectively absent, which limits comparison on dividend yield.

For that reason, the recovery in operating margin and the trend in quarterly profit serve as the starting point for valuation reading.

The third-quarter 2026 operating loss narrowed year on year while the net loss attributable to controlling shareholders widened, so how much non-operating drag falls away is the key point of comparison.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Overseas ESS demand expansion

The company said in June 2025 that it planned to supply about 60,000 tons of ESS electrolyte in 2026. ESS made up about 70% of supply at the Chinese subsidiary in 2025, ahead of EV-use supply. Sample evaluation or supply talks with six North American, ten Chinese and seven European customers add to the demand base.

Quarterly sales recovery and volume growth

Sales rose in the second and third quarters of 2026 to KRW 102.3 billion and KRW 109 billion, with third-quarter sales up 20.8% year on year. The company announced in June 2026 that first-quarter electrolyte volume rose 12.1% year on year to 12,155 tons. The third-quarter 2026 operating loss of KRW 14.7 billion narrowed from KRW 27.2 billion a year earlier.

Remaining large contracts and production base

At the end of 2025 the company said it had already contracted about KRW 1.5 trillion of a roughly KRW 3 trillion new supply pipeline. Talks for the remainder target signing within 2025 or by the first quarter of 2027.

The Chinese subsidiary has annual capacity of about 220,000 tons, and the company also operates plants in Georgia and Poland.

09

Bear factors

Five straight quarters of losses

Both operating loss and the net loss attributable to controlling shareholders have persisted for five consecutive quarters from the third quarter of 2025 through the third quarter of 2026. The four-quarter total of that net loss is KRW 168.5 billion. The third-quarter 2026 net loss of KRW 59.9 billion was larger than KRW 35.9 billion a year earlier.

Price competition in China

In September 2026 the company said oversupply and price competition in China made profitability hard to secure through volume growth alone. Its shift toward selective order intake and price adjustments could slow the pace of sales growth.

The Chinese sales subsidiary posted KRW 81 billion in first-half 2026 sales, more than 2.5 times the KRW 31.5 billion of a year earlier, but that expansion is a volume effect and should be read apart from profitability.

Non-operating losses and capital structure

The 2024 net loss attributable to controlling shareholders of KRW 555.4 billion was far larger than the KRW 50.4 billion operating loss, so non-operating items weighed heavily. Total liabilities of KRW 626.5 billion at the end of 2025 exceeded total equity of KRW 481 billion, with a debt ratio of 130.2%.

Conversion requests on convertible bonds issued at the end of 2024 rose in 2025, which is cited as a dilution factor.

10

Risk factors

Order execution and customer concentration

CATL-bound ESS LFP electrolyte is still moving through quality audit, evaluation and approval before mass supply is decided. With a customer base concentrated among large Chinese battery makers, delays or volume changes at one customer feed directly into sales.

The remaining roughly KRW 1.5 trillion of orders also has an open signing window running to year-end 2026 or the first quarter of 2027.

Changes to North American production plans

A 2025 report said the planned Tennessee plant had been scrapped. The plan to expand Georgia capacity to 200,000 tons could also shift with timing changes. Because the earnings path leans heavily on North American expansion, changes in those plans carry weight.

Funding needs and share dilution

In 2025 the company said it would put KRW 200 billion of funds raised toward facility investment. Conversion requests on bonds issued at the end of 2024 picked up in 2025, and some earlier investors have exited.

Whether raw-material price changes pass through to selling prices is also part of order terms, so cost pressure can affect profit.

11

What to watch next

  1. End of December 2026

    Whether the Georgia plant reaches its year-end capacity target, and whether the added output shows up in North American sales.

  2. December 2026 to end of March 2027

    Whether the remaining roughly KRW 1.5 trillion of new orders is signed within the targeted window, and at what size.

  3. January to February 2027 (date not fixed)

    Whether the fourth-quarter 2026 preliminary results extend the loss streak and whether sales growth translates into narrower losses.

  4. End of March 2027 (statutory filing deadline)

    The 2026 annual report will confirm full-year sales, operating results, net income attributable to controlling shareholders and capital structure.

  5. Date not fixed (after approval completes)

    Whether CATL-bound ESS LFP electrolyte begins mass supply and whether that supports the Chinese business's profit structure.

12

Overall view

Enchem's disclosed results show sales falling from KRW 509.8 billion in 2022 to KRW 312.8 billion in 2025, while operating margin moved from 3.0% to -25.1%.

Sales rose in the second and third quarters of 2026, and the third-quarter operating loss narrowed year on year, but the net loss attributable to controlling shareholders widened to KRW 59.9 billion.

On the bullish side, the cited points are the rising ESS share at the Chinese subsidiary, expanding sample evaluations in North America and Europe, and the remaining large contract pipeline.

On the bearish side, the points are five straight quarters of losses, oversupply and price competition in China, and non-operating drag together with dilution from convertible bonds.

On valuation, no earnings-based multiple can be calculated and the price-to-book ratio sits below 1x, so the recovery of operating indicators is the starting point for reading the stock.

The next checkpoints are completion of the Georgia expansion, signing of the remaining orders, the fourth-quarter 2026 preliminary results and the 2026 annual report. This report offers no investment opinion, rating or target price and is provided for information only.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. paxetv.com
  2. finance-scope.com
  3. epnc.co.kr
  4. businessreport.kr
  5. view.asiae.co.kr
  6. view.asiae.co.kr
  7. ddaily.co.kr
  8. finance-scope.com
  9. dealsite.co.kr
  10. view.asiae.co.kr
  11. m.thebell.co.kr
  12. dt.co.kr
  13. dealsite.co.kr
  14. sisaon.co.kr
  15. atlantak.com
  16. edaily.co.kr
  17. asiae.co.kr
  18. thetracker.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis